Qinghui Kan
Overview
Explore the profile of Qinghui Kan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
3
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhou Z, Deng T, Liu S, Huang L, Wang K, Kan Q, et al.
Mol Biol Rep
. 2024 Nov;
51(1):1127.
PMID: 39508893
Background: Developing a molecular signature associated with CD4 + T cell infiltration is essential for identifying biomarkers in abdominal aortic aneurysms (AAA). Establishing such a signature is vital for improving...
2.
Kan Q, Peng Z, Wang K, Deng T, Zhou Z, Wu R, et al.
J Transl Med
. 2024 Sep;
22(1):871.
PMID: 39334121
Lower limb arterial occlusive disease is treated with intraluminal devices, such as paclitaxel (PTX)-coated balloons (PCBs); however, post-procedural restenosis remains a significant challenge. NLRP3 activation is known to play a...
3.
Peng Z, Kan Q, Wang K, Deng T, Wang S, Wu R, et al.
BMC Genomics
. 2024 May;
25(1):490.
PMID: 38760675
Background: Ruptured atherosclerotic plaques often precipitate severe ischemic events, such as stroke and myocardial infarction. Unraveling the intricate molecular mechanisms governing vascular smooth muscle cell (VSMC) behavior in plaque stabilization...
4.
Wang K, Zhou Z, Huang L, Kan Q, Wang Z, Wu W, et al.
Biochim Biophys Acta Mol Basis Dis
. 2024 Jan;
1870(2):166919.
PMID: 38251428
Abdominal aortic aneurysm (AAA) is typically asymptomatic but a devastating cardiovascular disorder, with overall mortality exceeding 80 % once it ruptures. Some patients with AAA may also have comorbid metabolic...
5.
Wang K, Kan Q, Ye Y, Qiu J, Huang L, Wu R, et al.
Front Genet
. 2022 Dec;
13:1055396.
PMID: 36482903
N-methyladenosine (m6A) is the most prevalent non-cap reversible modification present in messenger RNAs and long non-coding RNAs, and its dysregulation has been linked to multiple cardiovascular diseases, including cardiac hypertrophy...